Clinical and laboratory evaluation of cefanone, a new cephalosporin antibiotic.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D002481:Cellulitis / Q000188:drug therapy; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D002512:Cephalothin / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004696:Endocarditis / Q000188:drug therapy; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D013997:Time Factors
D002511:Cephalosporins; D002509:Cephaloridine; D002512:Cephalothin